Patient perceptions and experiences of stereotactic radiotherapy for wet age-related macular degeneration

European Journal of Ophthalmology
Hugo SenraTariq Aslam

Abstract

Wet age-related macular degeneration (ARMD) is a leading cause of visual impairment. Anti-vascular endothelial growth factor (VEGF) injections are the mainstay of treatment but require monthly injections and frequent hospital visits. A novel approach to treatment with the use of stereotactic radiotherapy (Oraya IRay) as an adjunct to ranibizumab injections has shown promising results. We explored patients' experiences of receiving Oraya therapy for wet ARMD. We present a consecutive case series with objective and detailed reporting of the personal experiences of 5 patients with active wet ARMD treated with Oraya radiotherapy in our unit. We provided all patients who had received one Oraya treatment with a standardized survey composed of 10 questions addressing the experience of receiving this treatment. Generally, patients reported positive experiences of receiving Oraya treatment and perceived this treatment as a better option in comparison with anti-VEGF injections. However, the patients' perceptions of Oraya treatment varied according to patients' previous experiences of anti-VEGF injections and expectations of treatment. Patients mainly justified their decision to receive Oraya treatment by expecting fewer intravitreal inje...Continue Reading

References

Feb 12, 2011·Clinical Ophthalmology·Robert Petrarca, Timothy L Jackson
Jul 1, 2014·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Christine McCloudKonrad Pesudovs

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

INTREPID
Oraya

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.